临床儿科杂志 ›› 2026, Vol. 44 ›› Issue (1): 38-43.doi: 10.12372/jcp.2026.24e1398

• 论著 • 上一篇    下一篇

White-Sutton综合征临床表型扩展及治疗尝试:病例系列报告

范瑞1,2, 张一宁2, 李辛1, 李娟1, 李群1, 李智颖1, 顾世立1, 胡斐涵1, 高诗阳1, 冯碧云1, 姚如恩3, 王秀敏1()   

  1. 1.上海交通大学医学院附属上海儿童医学中心内分泌代谢科(上海 200127)
    2.吉林大学第一医院儿童医院小儿内分泌遗传代谢科(吉林长春 130000)
    3.上海交通大学医学院附属上海儿童医学中心遗传分子诊断科(上海 200127)
  • 收稿日期:2024-12-30 录用日期:2025-10-22 出版日期:2026-01-15 发布日期:2026-01-05
  • 通讯作者: 王秀敏 电子信箱:wangxiumin@scmc.com.cn
  • 基金资助:
    中国国家重点研发计划(2022YFC2703102);上海市儿童罕见病临床研究中心(20MC1920400);上海市卫生和计划生育委员会(20204Y0346)

Clinical phenotype expansion and treatment attempts of White-Sutton syndrome: a series of case reports

FAN Rui1,2, ZHANG Yining2, LI Xin1, LI Juan1, LI Qun1, LI Zhiying1, GU Shili1, HU Feihan1, GAO Shiyang1, FENG Biyun1, YAO Ruen3, WANG Xiumin1()   

  1. 1. Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
    2. Department of Pediatric Endocrinology, Genetics and Metabolism, Children's Medical Center, The First Hospital of Jilin University, Changchun 130000, Jilin, China
    3. Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
  • Received:2024-12-30 Accepted:2025-10-22 Published:2026-01-15 Online:2026-01-05

摘要:

目的 White-Sutton综合征(WHSUS)是一种表型差异极大的单基因遗传病,本研究旨在进一步扩展WHSUS的临床表型谱,并探讨潜在改善症状的治疗方法。方法 回顾性分析2018年7月至2023年2月就诊于上海儿童医学中心的4例WHSUS患儿的临床资料。结果 4例患儿首诊年龄范围为1~9岁,男2例、女2例,均有语言及运动发育落后。例1,女,表现为既往未报道过的临床表型,即脊髓栓系综合征(TCS),同时患有胰岛素抵抗。例2,女,因身材矮小和学习成绩差就诊,患儿接受了3.5年的生长激素治疗,随访至12岁1个月时,身高为152 cm(P50),月经正常。例3,男,因语言发育迟缓就诊。例4,男,语言发育迟缓且有孤独症谱系障碍倾向。此4例均存在POGZ基因新生变异,诊断为WHSUS。结论 本研究详细报道了4例WHSUS患者的临床特征,扩展了WHSUS的表型谱。同时,首次报道了WHSUS伴身材矮小患儿应用生长激素的治疗尝试,为此类疾病的对症治疗提供了新的思路。

关键词: White-Sutton综合征, POGZ基因, 脊髓栓系综合征

Abstract:

Objective White-Sutton syndrome (WHSUS) is a monogenic genetic disorder with significant phenotypic differences. This study aims to further expand the clinical phenotypic spectrum of WHSUS and explore potential treatment methods for improving symptoms. Methods A retrospective analysis was conducted on the clinical data of four WHSUS patients who visited Children's Medical Center from July 2018 to February 2023. Results The age range of the first diagnosis of the 4 patients was 1-9 years old, 2 boys and 2 girls, all of whom had delayed language and motor development. Patient 1, a girl, exhibited a previously unreported clinical phenotype, tethered cord syndrome (TCS), and concurrent insulin resistance. Patient 2, a girl, visited the doctor due to short stature and poor academic performance. She received growth hormone treatment for 3.5 years. At the age of 12 years and 1 month during the follow-up, her height was 152 cm (P50), and her menstruation was normal. Patient 3, a boy, was treated for delayed language development. Patient 4 was a boy with delayed language development and autistic tendency. All four patients had de novo mutations in the POGZ gene and were diagnosed with WHSUS. Conclusions This study detailedly reported the clinical features of 4 patients with WHSUS, expanding the phenotypic spectrum of WHSUS. Meanwhile, it was the first to report the treatment attempt of growth hormone for a child with WHSUS and short stature, providing a new idea for the symptomatic treatment of this kind of disease.

Key words: White-Sutton syndrome, POGZ gene, tethered cord syndrome

中图分类号: 

  • R72